ACTRN12611000351910进行中（未招募）4 期
The Effect of Pioglitazone on Left Ventricular Mass and Function, Plasma Levels of Inflammatory and Endothelial Biomarkers and Psychiatric Indicators in non-Diabetic Patients with Metabolic Syndrome
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Patients with Metabolic Syndrome (National Cholesterol Education Program/ATP III Criteria), New York Heart Association Functional Class 1 or 2, BMI 25 to 32 kg/m2
排除标准
- •Patients with type 2 diabetes (American Diabetes Association Criteria), Current or prior use of Pioglitazone or Rosiglitazone within the preceding 3 months, Current use of Glucocorticoids, Any history or evidence of ischemic heart disease, Patients with vulvular heart disease, Patients with uncontrolled hypertention (>140/90 mmHg), Patients with LV Systolic dysfunction diagnosed by Doppler Echocardiography (EF < 40%), Patients with Restrictive or Constrictive Cardiomyopathy and/or Pericarditis, Patients with Infectious Endocarditis, Patients with impaired Renal function (plasma creatinine > 1.5 mg/dl) or Hepatic function (ALT > 3 times of upper limit of normal), Chronic systemic inflammatory disease (eg. Rheumatoid disorders), Anemia (Hb < 13 mg/dl in Men & Hb < 12 mg/dl in Women), Pregnancy or Lactating, Alcohol or Drug abuse, Any debilitating medical condition
研究者
相似试验
已完成
4 期
The effect of Pioglitazone on Cardiovascular and Psychiatric status of non-Diabetic Metabolic Syndrome PatientsMetabolic Syndrome.Metabolic disorder, unspecifiedIRCT201101023733N2Osvah Pharmaceutical Company140
进行中（未招募）
1 期
The effect of Pioglitazone on vascular and ventricular function in people with type 2 diabetes PICCOLA - PICCOLADiabetesEUCTR2007-001222-27-GBImperial College London24
尚未招募
Unknown
The Impact of Empagliflozin on Left Ventricular Myocardial Stiffness in Heart Failure with Preserved Ejection FractioPatients with heart failure with preserved ejecion fraction (HFpEF)Drug intervention, Empagliflozin, Pressure-Volume LoopHFpEF/I509JPRN-jRCTs071230020Hieda Michinari38
已完成
不适用
Effects of Luseogliflozin on Left Ventricular Diastolic Function in Patients with Type 2 Diabetes and Established Cardiovascular DiseaseThe patients with type 2 diabetes and cardiovascular diseaseJPRN-UMIN000040442Saiseikai Fukuoka General Hospital25
已完成
4 期
Effect of pioglitazone on cardiovascular events in high-risk diabetic patients with acute brain infarctioAcute brain infarction with type2 diabetes mellitus.JPRN-UMIN000001112Kyushu University600